相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endothelin receptors: what's new and what do we need to know?
Stephanie W. Watts
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Preventive Effect of Chronic Endothelin Type A Receptor Antagonist on Coronary Microvascular Spasm Induced by Repeated Epicardial Coronary Artery Endothelial Denudation in Pigs
Taku Osugi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Improved myocardial perfusion preceding clinical response on bosentan treatment for coronary vasospasm
Ilse A. C. Vermeltfoort et al.
ACTA CARDIOLOGICA (2009)
Vascular control in humans: focus on the coronary microcirculation
Yanping Liu et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Inflammatory cytokines in vascular dysfunction and vascular disease
Alexander H. Sprague et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation
Dyah W. Anggrahini et al.
CARDIOVASCULAR RESEARCH (2009)
Vascular endothelial ageing, heartbeat after heartbeat
Eric Thorin et al.
CARDIOVASCULAR RESEARCH (2009)
Novel pathway of endothelin-1 and reactive oxygen species in coronary vasospasm with endothelial dysfunction
Shu-Ichi Saitoh et al.
CORONARY ARTERY DISEASE (2009)
Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: Role of ETB-receptor expression levels
Stephanie Sauvageau et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2009)
Endothelin-1 signalling in vascular smooth muscle: Pathways controlling cellular functions associated with atherosclerosis
Melanie E. Ivey et al.
ATHEROSCLEROSIS (2008)
Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents
G. Heusch
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?
N. S. Kirkby et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease
Felix Bohm et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2008)
Endothelin: 20 years from discovery to therapy
Matthias Barton et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2008)
Endothelin-1, aging and hypertension
Brian L. Stauffer et al.
CURRENT OPINION IN CARDIOLOGY (2008)
Endothelin-1 potentiation of coronary artery contraction after ischemia-reperfusion
Angel Luis Garcia-Villalon et al.
VASCULAR PHARMACOLOGY (2008)
The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries
Huseyin Celebi et al.
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2008)
Endogenous endothelin in human coronary vascular function - Differential contribution of endothelin receptor types A and B
Julian P. J. Halcox et al.
HYPERTENSION (2007)
Coronary endothelium expresses a pathologic gene pattern compared to aortic endothelium:: Correlation of asynchronous hemodynamics and pathology in vivo
Michael B. Dancu et al.
ATHEROSCLEROSIS (2007)
Vasoactive peptides in cardiovascular (patho)physiology
Glaucia Callera et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2007)
Endothelin-1-induced pulmonary vasoreactivity is regulated by ETA and ETB receptor interactions
Stephanie Sauvageau et al.
JOURNAL OF VASCULAR RESEARCH (2007)
Towards triple vasopeptidase inhibitors for the treatment of cardiovascular diseases
Philippe Daull et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Cardiovascular endothelins:: Essential regulators of cardiovascular homeostasis
Friedrich Brunner et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats
P Daull et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion.: Role of endothelin receptors, nitric oxide and prostanoids
B Climent et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
The Role of Endothelin in Heart Failure
Allan D. Angerio
CRITICAL CARE NURSING QUARTERLY (2005)
Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells:: role of ETB receptor, NADPH oxidase and caveolin-1
F Dong et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide
S Wedgwood et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice
LL Yang et al.
CIRCULATION (2004)
The nitric oxide-endothelin-1 connection
D Alonso et al.
HEART FAILURE REVIEWS (2003)
Function of the endothelinB receptor in cardiovascular physiology and pathophysiology
P D'Orleans-Juste et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade
MR Dashwood et al.
ATHEROSCLEROSIS (2002)
Coronary vasodilation and improvement in endothelial dysfunction with endothelin ETA receptor blockade
JPJ Halcox et al.
CIRCULATION RESEARCH (2001)
Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries
S Kinlay et al.
CIRCULATION (2001)
Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis
C Ihling et al.
CIRCULATION (2001)
Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies
E Thorin
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
Different contribution of endothelial nitric oxide in the relaxation of human coronary arteries of ischemic and dilated cardiomyopathic hearts
E Thorin
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
Endothelin system: The double-edged sword in health and disease
RM Kedzierski et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey
SA Douglas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology
KK Griendling et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease
F Ruschitzka et al.
CIRCULATION (2000)
Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriography
ZS Kyriakides et al.
HEART (2000)
分享论文
